ÇAKIR, B. 2020. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8 , 2068-2069.

ÇAKIR, B., (2020). Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, 2068-2069.

ÇAKIR, BANU. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, 2068-2069, 2020

ÇAKIR, BANU. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, pp.2068-2069, 2020

ÇAKIR, B. (2020) . "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.8, pp.2068-2069.

@article{article, author={BANU ÇAKIR}, title={Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={2068-2069} }